Actelion Pharmaceuticals Ltd is a biopharmaceutical company headquartered in Allschwil/Basel, Switzerland, focusing on the discovery, development and commercialization of innovative treatments to serve high unmet medical needs. For further details please
6th largest company in the field of plasma-derived medicinal products worldwide, LFB is a leader in France in this area, and features among the major European biotechnologies stakeholders. A recognized expert in immunology, intensive care and haemostasis, LFB develops, manufactures and sells medicinal products for the treatment of diseases always serious and often rare. LFB has expertise in biological medicinal products. Its developments focus on creating advanced therapies that aim to meet essential public health requirements. Each year, significant investment is made in research and development. LFB’s commitment to the treatment of rare diseases is one of the company’s long-standing cornerstones of its activity.
Lab Bailleul, an independent pharmaceutical group established in France in 1949. Since then company has achieved significant international development. Laboratories Bailleul now develop and market medicinal products that enable comprehensive patient management in its main areas of activity, Dermatology and Family Medicine.
KERN PHARMA is leader in generic medicine development & production. Kern Pharma is an Indukern group company. With its purchase of a pharmaceutical plant from the Roche group in 1999, the Indukern group consolidated its strategy in the area of human health. Today Kern Pharma is one of Spain’s leading generic company with its strong foothold in rest of Europe. Business of Kern Pharma is divided in two major lines;
Designed in Monaco, Made in France
DENSMORE Pharmaceutical is based in Monaco since 1946. Tradition, Quality and Innovation are hallmark of DENSMORE.
Its centre of research and development possesses about 70 years of expertise in vitamin therapy and micro-nutrition. Since the early 2000’s the laboratory has acquired a new expertise in drugs, medical devices and cosmetics and received two innovation and research awards. These awards, reward its research unit and the entire range.
Flen Pharma is a privately owned company established in year 2000 based in Luxembourg. Build on strong research in management of wound-treatment, Flen Pharma’s products for wound healing are based on moist-wound healing principle and originates from patented polymer applications and patented enzyme complexes.
Hematris Wound Care GmbH, is devoted to development, production & marketing of hemostatic products. Hematris is recognized and regarded as expertise in field of hemostasis and wound healing. Hematris has vision to fulfill the life-threating situation where quick and effective hemostasis is vital with its break through products.
Orion is a globally operating Finnish developer of pharmaceuticals and diagnostic tests – a builder of well-being. Market leader in Finland while Products available in more than 100 countries. Orion develops, manufactures and markets human and veterinary pharmaceuticals, active pharmaceutical ingredients and diagnostic tests. It is continuously developing new drugs and treatment methods. The core therapy areas of Orion’s pharmaceutical are Respiratory, CNS & Oncology drugs. Orion’s products are sold by several collaboration partners worldwide.
RAFARM began its activities in 1974. A company created with a business belief of “high quality medicines at affordable prices”, a people-oriented organizational structure and quick reflexes in the business arena.
Since then RAFARM has grown, expanded its activities, initiated international partnerships and created its own production facilities. Today, more than 150 different pharmaceutical products, an expanding presence in the domestic and international market – exports and partnerships with leading companies in Europe and all over the world -, as well as a remarkable position in health professionals perception, are the result of RAFARM’s successful course.